Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions - Top-Institutions - MDSpire

Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions

  • By

  • Andriy Prodan

  • Ihor Dzyubanovsky

  • Iryna Halabitska

  • Pavlo Petakh

  • Iryna Kamyshna

  • Oleksandr Kamyshnyi

  • May 20, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Bariatric Surgery
    • Obesity Research

  • #2

    Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Endocrinology
    • Bariatric Surgery
    • Obesity Research

  • #3

    Medical University of Gdańsk
    Medical University of Gdańsk

    Gdańsk, Poland

    Key Differentiators

    • Endocrinology
    • Bariatric Surgery

  • #4

    Copenhagen University Hospital, Hvidovre
    Copenhagen University Hospital, Hvidovre

    Hvidovre, Denmark

    Key Differentiators

    • Endocrinology
    • Bariatric Surgery

  • #5

    St Vincent’s Hospital
    St Vincent’s Hospital

    Melbourne, Australia

    Key Differentiators

    • Endocrinology
    • Bariatric Surgery

Original Source(s)

Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions

  • by Andriy Prodan, Ihor Dzyubanovsky, Iryna Halabitska, Pavlo Petakh, Iryna Kamyshna, Oleksandr Kamyshnyi

  • May 20, 2026

Related Content

Global Trends and Research Topics in Gastric Bypass Clinical Trials: A Bibliometric Analysis and Latent Dirichlet Allocation (LDA) Study

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases